Tigris Dts Gen-Probe Aptima Combo 2 Assay
Dna-Reagents, Neisseria. 510(k) K060652, from Gen-Probe, Inc. (San Diego, CA). Product code LSL, class 2.
As of Nov 21, 2026, K060652 is an FDA 510(k) held by Gen-Probe, Inc., substantially equivalent on Aug 17, 2006 after 157 days, with no recalls tied to it in FDA's recall database.
- Review time: 157 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The APTIMA COMBO 2 Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis and/or Neisseria gonorrhoeae in clinician-collected endocervical, vaginal and male urethral swab specimens, patient-collected vaginal swab specimens 1 , female and male urine specimens…
- Aptima Combo 2 Assay (Panther) - 250 test kit, Aptima Combo 2 Assay (Tigris) - 250 test kit, Aptima Trichomonas…K200436 · Hologic, Inc. · Mar 23, 2020
- Cobas 4800 CT / NG TestK110923 · Roche Molecular Systems, Inc. · Jan 24, 2012
- Aptima Neisseria gonorrhoeae AssayK231329 · Hologic, Inc. · Jan 26, 2024
- Type
- Traditional
- Received
- Mar 13, 2006
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3390
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files